{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:44:02Z","timestamp":1768344242212,"version":"3.49.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011776","name":"Instituto Portugu\u00eas de Oncologia do Porto","doi-asserted-by":"publisher","award":["CI-IPOP-22-2015"],"award-info":[{"award-number":["CI-IPOP-22-2015"]}],"id":[{"id":"10.13039\/501100011776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011733","name":"Liga Portuguesa Contra o Cancro","doi-asserted-by":"publisher","award":["LPCC-NRN2023-BVN"],"award-info":[{"award-number":["LPCC-NRN2023-BVN"]}],"id":[{"id":"10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.08969.BD"],"award-info":[{"award-number":["2020.08969.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-024-02983-2","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:13:16Z","timestamp":1713669196000},"page":"815-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies"],"prefix":"10.1007","volume":"57","author":[{"given":"Beatriz Vieira","family":"Neto","sequence":"first","affiliation":[]},{"given":"Val\u00e9ria","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Brito","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Liz-Pimenta","sequence":"additional","affiliation":[]},{"given":"In\u00eas Soares","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Lurdes","family":"Salgado","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Deolinda","family":"Pereira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"2983_CR1","doi-asserted-by":"crossref","unstructured":"Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. American College of Cardiology Foundation Washington, DC, pp 2529\u20132532","DOI":"10.1016\/j.jacc.2019.10.009"},{"issue":"2","key":"2983_CR2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41397-020-00201-9","volume":"21","author":"V Tavares","year":"2021","unstructured":"Tavares V, Pinto R, Assis J, Coelho S, Brandao M, Alves S, Pereira D, Medeiros R (2021) Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients. Pharmacogenomics J 21(2):222\u2013232","journal-title":"Pharmacogenomics J"},{"key":"2983_CR3","unstructured":"DeVita VT, Lawrence TS, Rosenberg SA (2008) DeVita, Hellman, and Rosenberg\u2019s cancer: principles & practice of oncology. Lippincott Williams & Wilkins"},{"key":"2983_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thromres.2019.11.009","volume":"185","author":"I de Araujo Trugilho","year":"2020","unstructured":"de Araujo Trugilho I, Renni MJP, Medeiros GC, Thuler LCS, Bergmann A (2020) Incidence and factors associated with venous thromboembolism in women with gynecologic cancer. Thromb Res 185:49\u201354","journal-title":"Thromb Res"},{"issue":"1","key":"2983_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","volume":"41","author":"JA Heit","year":"2016","unstructured":"Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41(1):3\u201314","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"2983_CR6","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","volume":"2","author":"W Lim","year":"2018","unstructured":"Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, Kline JA, Chasteen S, Snyder M, Patel P (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv 2(22):3226\u20133256","journal-title":"Blood Adv"},{"key":"2983_CR7","doi-asserted-by":"crossref","unstructured":"Liz-Pimenta J, Tavares V, Neto BV, Santos JM, Guedes CB, Ara\u00fajo A, Khorana AA, Medeiros R (2023) Thrombosis and cachexia in cancer: two partners in crime? Crit Rev Oncol\/Hematol 103989","DOI":"10.1016\/j.critrevonc.2023.103989"},{"issue":"1","key":"2983_CR8","first-page":"452","volume":"2005","author":"M Cushman","year":"2005","unstructured":"Cushman M (2005) Inherited risk factors for venous thrombosis. ASH Educ Program Book 2005(1):452\u2013457","journal-title":"ASH Educ Program Book"},{"issue":"3","key":"2983_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10238-022-00829-w","volume":"23","author":"S Navarrete","year":"2023","unstructured":"Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I (2023) Pathophysiology of deep vein thrombosis. Clin Experimental Med 23(3):645\u2013654","journal-title":"Clin Experimental Med"},{"issue":"1","key":"2983_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41983-019-0093-8","volume":"55","author":"S Kaur","year":"2019","unstructured":"Kaur S, Ali A, Ahmad U, Siahbalaei Y, Pandey A, Singh B (2019) Role of single nucleotide polymorphisms (SNPs) in common migraine. Egypt J Neurol Psychiatry Neurosurg 55(1):1\u20137","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"1","key":"2983_CR11","doi-asserted-by":"crossref","first-page":"188331","DOI":"10.1016\/j.bbcan.2019.188331","volume":"1873","author":"V Tavares","year":"2020","unstructured":"Tavares V, Pinto R, Assis J, Pereira D, Medeiros R (2020) Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: linkage to ovarian tumour behaviour. Biochim et Biophys Acta (BBA)-Reviews Cancer 1873(1):188331","journal-title":"Biochim et Biophys Acta (BBA)-Reviews Cancer"},{"key":"2983_CR12","doi-asserted-by":"crossref","unstructured":"Fernandes CJ, Morinaga LTK, Alves JLJ, Castro MA, Calderaro D, Jardim CVP, Souza R (2019) Cancer-associated thrombosis: the when, how and why. Eur Respir Rev 28(151)","DOI":"10.1183\/16000617.0119-2018"},{"issue":"4","key":"2983_CR13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","volume":"20","author":"PL Lutsey","year":"2023","unstructured":"Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Reviews Cardiol 20(4):248\u2013262","journal-title":"Nat Reviews Cardiol"},{"issue":"4","key":"2983_CR14","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.thromres.2013.01.027","volume":"131","author":"T Satoh","year":"2013","unstructured":"Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M, Minaguchi T, Sakurai H (2013) Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb Res 131(4):e127\u2013e132","journal-title":"Thromb Res"},{"key":"2983_CR15","doi-asserted-by":"crossref","unstructured":"Tavares V, Neto BV, Vilas-Boas MI, Pereira D, Medeiros R (2022) Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: a review of existing evidence, Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 188778","DOI":"10.1016\/j.bbcan.2022.188778"},{"key":"2983_CR16","doi-asserted-by":"crossref","unstructured":"Tavares V, Neto BV, Marques IS, Assis J, Pereira D, Medeiros R (2023) Cancer-associated thrombosis: what about microRNAs targeting the tissue factor coagulation pathway? Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 189053","DOI":"10.1016\/j.bbcan.2023.189053"},{"issue":"1","key":"2983_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-022-00335-z","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AY (2022) Cancer-associated venous thromboembolism. Nat Reviews Disease Primers 8(1):1\u201318","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"2983_CR18","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1038\/s41598-023-36161-w","volume":"13","author":"BV Neto","year":"2023","unstructured":"Neto BV, Tavares V, da Silva JB, Liz-Pimenta J, Marques IS, Carvalho L, Salgado L, Pereira D, Medeiros R (2023) Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer. Sci Rep 13(1):9519","journal-title":"Sci Rep"},{"issue":"2","key":"2983_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","volume":"26","author":"J Prat","year":"2015","unstructured":"Prat J, Oncology FCoG (2015) FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol 26(2):87\u201389","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2983_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brachy.2018.08.016","volume":"18","author":"BA Quinn","year":"2019","unstructured":"Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC (2019) Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy 18(1):29\u201337","journal-title":"Brachytherapy"},{"issue":"1","key":"2983_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AOG.0000000000003311","volume":"134","author":"JD Wright","year":"2019","unstructured":"Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, Clair CMS, Ananth CV, Neugut AI, Hershman DL (2019) Prognostic performance of the 2018 International Federation of Gynecology and Obstetrics cervical cancer staging guidelines. Obstet Gynecol 134(1):49","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2983_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AY (2022) Cancer-associated venous thromboembolism. Nat Reviews Disease Primers 8(1):11","journal-title":"Nat Reviews Disease Primers"},{"key":"2983_CR23","doi-asserted-by":"crossref","unstructured":"Falanga A, Marchetti M (2023) Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost","DOI":"10.1016\/j.jtha.2023.02.029"},{"key":"2983_CR24","doi-asserted-by":"crossref","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang Y, Roest M, de Laat B, de Groot PG, Huskens D (2021) Interplay between platelets and coagulation. Blood Rev 46:100733","journal-title":"Blood Rev"},{"issue":"1","key":"2983_CR25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1470-2045(07)70409-6","volume":"9","author":"L Barbera","year":"2008","unstructured":"Barbera L, Thomas G (2008) Venous thromboembolism in cervical cancer. Lancet Oncol 9(1):54\u201360","journal-title":"Lancet Oncol"},{"issue":"2","key":"2983_CR26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2009.01.021","volume":"113","author":"G Jacobson","year":"2009","unstructured":"Jacobson G, Lammli J, Zamba G, Hua L, Goodheart MJ (2009) Thromboembolic events in patients with cervical carcinoma: incidence and effect on survival. Gynecol Oncol 113(2):240\u2013244","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2983_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2016.06.012","volume":"142","author":"K Matsuo","year":"2016","unstructured":"Matsuo K, Moeini A, Machida H, Fullerton ME, Shabalova A, Brunette LL, Roman LD (2016) Significance of venous thromboembolism in women with cervical cancer. Gynecol Oncol 142(3):405\u2013412","journal-title":"Gynecol Oncol"},{"issue":"7","key":"2983_CR28","first-page":"1514","volume":"98","author":"T Wun","year":"2003","unstructured":"Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK (2003) Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. CA Cancer J Clin 98(7):1514\u20131520","journal-title":"CA Cancer J Clin"},{"key":"2983_CR29","doi-asserted-by":"crossref","unstructured":"Temkin S, Hellmann M, Serur E, Lee Y-C, Abulafia O (2006) Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation. Int J Gynecol Cancer 16(5)","DOI":"10.1136\/ijgc-00009577-200609000-00020"},{"issue":"1","key":"2983_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2006.01.007","volume":"79","author":"R P\u00f6tter","year":"2006","unstructured":"P\u00f6tter R, Dimopoulos J, Bachtiary B, Sissolak G, Klos B, Rheinthaller A, Kirisits C (2006) Knocke-Abulesz, 3D conformal HDR-brachy-and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up. Radiother Oncol 79(1):80\u201386","journal-title":"Radiother Oncol"},{"issue":"2","key":"2983_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ygyno.2007.10.011","volume":"108","author":"G Thomas","year":"2008","unstructured":"Thomas G, Ali S, Hoebers FJ, Darcy KM, Rodgers WH, Patel M, Abulafia O, Lucci JA III, Begg AC (2008) Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0\u00a0g\/dL with erythropoietin vs above 10.0\u00a0g\/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 108(2):317\u2013325","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2983_CR32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2004.10.023","volume":"96","author":"GM Jacobson","year":"2005","unstructured":"Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ (2005) Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer. Gynecol Oncol 96(2):470\u2013474","journal-title":"Gynecol Oncol"},{"issue":"14","key":"2983_CR33","first-page":"1959","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e0th-Puh\u00f3 E, van Es N, Van Laarhoven H, Pedersen L, Moik F, Ay C, B\u00fcller H, S\u00f8rensen H (2021) Venous thromboembolism in cancer patients: a population-based cohort study, blood. J Am Soc Hematol 137(14):1959\u20131969","journal-title":"J Am Soc Hematol"},{"key":"2983_CR34","doi-asserted-by":"crossref","unstructured":"Howe K.L., Achuthan P., Allen J., Allen J., Alvarez-Jarreta J., Amode M.R., Armean I.M., Azov A.G., Bennett R., Bhai J. (2021) Ensembl 2021. Nucleic Acids Res 49D1:D884\u2013D891","DOI":"10.1093\/nar\/gkaa942"},{"issue":"18","key":"2983_CR35","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1002\/cncr.25213","volume":"116","author":"H Ju","year":"2010","unstructured":"Ju H, Lim B, Kim M, Noh SM, Kim WH, Ihm C, Choi BY, Kim YS, Kang C (2010) SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility. Cancer 116(18):4248\u20134255","journal-title":"Cancer"},{"issue":"7","key":"2983_CR36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/02713683.2016.1276197","volume":"42","author":"V Siokas","year":"2017","unstructured":"Siokas V, Dardiotis E, Sokolakis T, Kotoula M, Tachmitzi SV, Chatzoulis DZ, Almpanidou P, Stefanidis I, Hadjigeorgiou GM, Tsironi EE (2017) Plasminogen activator inhibitor type-1 tag single-nucleotide polymorphisms in patients with diabetes mellitus type 2 and diabetic retinopathy. Curr Eye Res 42(7):1048\u20131053","journal-title":"Curr Eye Res"},{"issue":"10","key":"2983_CR37","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/jth.15468","volume":"19","author":"PT Williams","year":"2021","unstructured":"Williams PT (2021) Quantile-specific heritability of plasminogen activator inhibitor type\u20101 (PAI\u20101, aka SERPINE1) and other hemostatic factors. J Thromb Haemost 19(10):2559\u20132571","journal-title":"J Thromb Haemost"},{"issue":"46","key":"2983_CR38","doi-asserted-by":"crossref","first-page":"e2314225120","DOI":"10.1073\/pnas.2314225120","volume":"120","author":"P Zhang","year":"2023","unstructured":"Zhang P, Chaldebas M, Ogishi M, Al Qureshah F, Ponsin K, Feng Y, Rinchai D, Milisavljevic B, Han JE, Moncada-V\u00e9lez M (2023) Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites. Proc Natl Acad Sci 120(46):e2314225120","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"2983_CR39","first-page":"4924","volume":"112","author":"DC Johnson","year":"2008","unstructured":"Johnson DC, Corthals S, Ramos C, Hoering A, Cocks K, Dickens NJ, Haessler J, Goldschmidt H, Child JA, Bell SE (2008) Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping, blood. J Am Soc Hematol 112(13):4924\u20134934","journal-title":"J Am Soc Hematol"},{"issue":"1","key":"2983_CR40","doi-asserted-by":"crossref","first-page":"12186","DOI":"10.1038\/s41598-022-16518-3","volume":"12","author":"H Furuya","year":"2022","unstructured":"Furuya H, Sasaki Y, Chen R, Peres R, Hokutan K, Murakami K, Kim N, Chan OT, Pagano I, Dyrskj\u00f8t L (2022) PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity. Sci Rep 12(1):12186","journal-title":"Sci Rep"},{"issue":"3","key":"2983_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MBC.0000000000001130","volume":"33","author":"OM Al-Amer","year":"2022","unstructured":"Al-Amer OM (2022) The role of thrombin in haemostasis. Blood Coagul Fibrinolysis 33(3):145\u2013148","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"2983_CR42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers11010100","volume":"11","author":"CJ Reddel","year":"2019","unstructured":"Reddel CJ, Tan CW, Chen VM (2019) Thrombin generation and cancer: contributors and consequences. Cancers 11(1):100","journal-title":"Cancers"},{"key":"2983_CR43","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S0049-3848(14)50013-8","volume":"133","author":"B \u00dcnl\u00fc","year":"2014","unstructured":"\u00dcnl\u00fc B, Versteeg HH (2014) Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor? Thromb Res 133:S76\u2013S84","journal-title":"Thromb Res"},{"issue":"4","key":"2983_CR44","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1002\/wrna.1474","volume":"9","author":"M Steri","year":"2018","unstructured":"Steri M, Idda ML, Whalen MB, Orr\u00f9 V (2018) Genetic variants in mRNA untranslated regions. Wiley Interdisciplinary Reviews: RNA 9(4):e1474","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"4","key":"2983_CR45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3899\/jrheum.100728","volume":"38","author":"FYK Demirci","year":"2011","unstructured":"Demirci FYK, Dressen AS, Kammerer CM, Barmada MM, Kao AH, Ramsey-Goldman R, Manzi S, Kamboh MI (2011) Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus. J Rhuematol 38(4):652\u2013657","journal-title":"J Rhuematol"},{"issue":"3","key":"2983_CR46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bjh.15004","volume":"180","author":"DA Tr\u00e9gou\u00ebt","year":"2018","unstructured":"Tr\u00e9gou\u00ebt DA, Morange PE (2018) What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies. Br J Haematol 180(3):335\u2013345","journal-title":"Br J Haematol"},{"key":"2983_CR47","doi-asserted-by":"crossref","unstructured":"Xia X, Fu J, Wu T, Chen W, Jiang S, Lv M, Zhang J (2022) Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin. Eur J Clin Pharmacol 1\u201310","DOI":"10.1007\/s00228-021-03204-y"},{"issue":"13","key":"2983_CR48","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.2010.31.8873","volume":"29","author":"CY Vossen","year":"2011","unstructured":"Vossen CY, Hoffmeister M, Chang-Claude JC, Rosendaal FR, Brenner H (2011) Clotting factor gene polymorphisms and colorectal cancer risk. J Clin Oncol 29(13):1722\u20131727","journal-title":"J Clin Oncol"},{"issue":"8","key":"2983_CR49","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.21474\/IJAR01\/5166","volume":"5","author":"I Baghad","year":"2017","unstructured":"Baghad I, Erguibi D, Chehab F, Nadifi S (2017) Risk of colorectal cancer and clotting factor gene polymorphisms in Moroccan Population. Int J Adv Res 5(8):1141","journal-title":"Int J Adv Res"},{"issue":"10294","key":"2983_CR50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA (2021) Venous thromboembolism. Lancet 398(10294):64\u201377","journal-title":"Lancet"},{"key":"2983_CR51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.thromres.2018.09.056","volume":"173","author":"S Barco","year":"2019","unstructured":"Barco S, Klok FA, Mah\u00e9 I, Marchena PJ, Ballaz A, Rubio CM, Adarraga MD, Mastroiacovo D, Konstantinides SV, Monreal M (2019) Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 173:166\u2013171","journal-title":"Thromb Res"},{"key":"2983_CR52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11239-009-0365-8","volume":"29","author":"M Montagnana","year":"2010","unstructured":"Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G (2010) The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 29:489\u2013496","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"2983_CR53","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/01.ATV.16.9.1170","volume":"16","author":"P-Y Scarabin","year":"1996","unstructured":"Scarabin P-Y, Vissac A-M, Kirzin J-M, Bourgeat P, Amiral J, Agher R, Guize L (1996) Population correlates of coagulation factor VII: importance of age, sex, and menopausal status as determinants of activated factor VII, Arterioscler. Thromb Vasc Biol 16(9):1170\u20131176","journal-title":"Thromb Vasc Biol"},{"issue":"10","key":"2983_CR54","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/jth.12372","volume":"11","author":"C Attard","year":"2013","unstructured":"Attard C, Van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V (2013) Developmental hemostasis: age-specific differences in the levels of hemostatic proteins. J Thromb Haemost 11(10):1850\u20131854","journal-title":"J Thromb Haemost"},{"key":"2983_CR55","doi-asserted-by":"crossref","unstructured":"Mari D, Ogliari G, Castaldi D, Vitale G, Bollini EM, Lio D (2008) Hemostasis and ageing, Immunity & Ageing 5(1) 1\u20134","DOI":"10.1186\/1742-4933-5-12"},{"key":"2983_CR56","doi-asserted-by":"crossref","unstructured":"Favaloro EJ, Franchini M, Lippi G (2014) Aging hemostasis: changes to laboratory markers of hemostasis as we age\u2014a narrative review, seminars in thrombosis and hemostasis. Thieme Medical, pp 621\u2013633","DOI":"10.1055\/s-0034-1384631"},{"key":"2983_CR57","doi-asserted-by":"crossref","unstructured":"Pieters M, Wolberg AS (2019) Fibrinogen and fibrin: An illustrated review, Research and practice in thrombosis and haemostasis 3(2) 161\u2013172","DOI":"10.1002\/rth2.12191"},{"issue":"6","key":"2983_CR58","first-page":"511","volume":"133","author":"JP Luyendyk","year":"2019","unstructured":"Luyendyk JP, Schoenecker JG, Flick MJ (2019) The multifaceted role of fibrinogen in tissue injury and inflammation, blood. J Am Soc Hematol 133(6):511\u2013520","journal-title":"J Am Soc Hematol"},{"key":"2983_CR59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.thromres.2019.11.002","volume":"184","author":"KB Jarvis","year":"2019","unstructured":"Jarvis KB, LeBlanc M, Tulstrup M, Nielsen RL, Albertsen BK, Gupta R, Huttunen P, J\u00f3nsson \u00d3G, Rank CU, Ranta S (2019) Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia\u2013A NOPHO ALL2008 study. Thromb Res 184:92\u201398","journal-title":"Thromb Res"},{"issue":"1","key":"2983_CR60","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1038\/s41598-023-31527-6","volume":"13","author":"LS Peschek","year":"2023","unstructured":"Peschek LS, Hobusch GM, Funovics PT, Willegger M, Schmid MP, Amann G, Lamm W, Brodowicz T, Ay C, Windhager R (2023) High fibrinogen levels are associated with poor survival in patients with liposarcoma. Sci Rep 13(1):8608","journal-title":"Sci Rep"},{"key":"2983_CR61","doi-asserted-by":"crossref","unstructured":"Paulsen B, Skille H, Smith EN, Hveem K, Gabrielsen ME, Br\u00e6kkan SK, Rosendaal FR, Frazer KA, Gran OV, Hansen J-B (2020) Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism, Haematologica 105(7) 1963","DOI":"10.3324\/haematol.2019.224279"},{"key":"2983_CR62","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(20)30396-0","volume":"191","author":"JT Buijs","year":"2020","unstructured":"Buijs JT, Versteeg HH (2020) Genes and proteins associated with the risk for cancer-associated thrombosis. Thromb Res 191:S43\u2013S49","journal-title":"Thromb Res"},{"key":"2983_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00932-z","volume":"13","author":"D Unruh","year":"2020","unstructured":"Unruh D, Horbinski C (2020) Beyond thrombosis: the impact of tissue factor signaling in cancer. J Hematol Oncol 13:1\u201314","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2983_CR64","first-page":"4075","volume":"16","author":"X Zhao","year":"2018","unstructured":"Zhao X, Cheng C, Gou J, Yi T, Qian Y, Du X, Zhao X (2018) Expression of tissue factor in human cervical carcinoma tissue. Experimental Therapeutic Med 16(5):4075\u20134081","journal-title":"Experimental Therapeutic Med"},{"issue":"5","key":"2983_CR65","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/cancers15051524","volume":"15","author":"N Hassan","year":"2023","unstructured":"Hassan N, Efing J, Kiesel L, Bendas G, G\u00f6tte M (2023) The tissue factor pathway in Cancer: overview and role of Heparan Sulfate proteoglycans. Cancers 15(5):1524","journal-title":"Cancers"},{"issue":"1","key":"2983_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-1","volume":"13","author":"C Xu","year":"2013","unstructured":"Xu C, Wang H, He H, Zheng F, Chen Y, Zhang J, Lin X, Ma D, Zhang H (2013) Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer. BMC Cancer 13(1):1\u20139","journal-title":"BMC Cancer"},{"issue":"11","key":"2983_CR67","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mc.20679","volume":"49","author":"B Stavik","year":"2010","unstructured":"Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010) Overexpression of both TFPI\u03b1 and TFPI\u03b2 induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells. Mol Carcinog 49(11):951\u2013963","journal-title":"Mol Carcinog"},{"issue":"12","key":"2983_CR68","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/cncr.10590","volume":"94","author":"R Pihusch","year":"2002","unstructured":"Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P, Hiller E (2002) Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 94(12):3120\u20133126","journal-title":"Cancer"},{"issue":"5","key":"2983_CR69","doi-asserted-by":"crossref","first-page":"e0194973","DOI":"10.1371\/journal.pone.0194973","volume":"13","author":"A Heraudeau","year":"2018","unstructured":"Heraudeau A, Delluc A, Le Henaff M, Lacut K, Leroyer C, Desrues B, Couturaud F, Tromeur C (2018) Risk of venous thromboembolism in association with factor V leiden in cancer patients\u2013the EDITH case-control study. PLoS ONE 13(5):e0194973","journal-title":"PLoS ONE"},{"key":"2983_CR70","first-page":"1","volume":"2020","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liao X-W, Qin Y-Z, Mo X-W, Luo S-S (2020) Identification of F5 as a prognostic biomarker in patients with gastric cancer. Biomed Res Int 2020:1\u201313","journal-title":"Biomed Res Int"},{"issue":"3","key":"2983_CR71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MBC.0000000000000242","volume":"26","author":"MA Wahba","year":"2015","unstructured":"Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZMA, Boshnak NH (2015) Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients. Blood Coagul Fibrinolysis 26(3):309\u2013315","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"2983_CR72","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjmed.2021.01.031","volume":"134","author":"AG Ording","year":"2021","unstructured":"Ording AG, Skj\u00f8th F, S\u00f8gaard M, H\u00f8jen AA, Overvad TF, Noble S, Goldhaber SZ, Larsen TB (2021) Increasing incidence and declining mortality after cancer-associated venous thromboembolism: a nationwide cohort study. Am J Med 134(7):868\u2013876e5","journal-title":"Am J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02983-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-024-02983-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-024-02983-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:14:40Z","timestamp":1720516480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-024-02983-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1007\/s11239-024-02983-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"9 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Portuguese Institute of Oncology of Porto (CES IPO:287\u00a0A\/014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent according to the principles of the Helsinki Declaration was obtained from each patient before their enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}